Synpr Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Gene Overview | |
|---|---|
| Gene Symbol | SYNPR |
| Full Name | Synaptophysin Family Member |
| Chromosomal Location | 4p16.3 |
| NCBI Gene ID | 140730 |
| OMIM | 616331 |
| Ensembl ID | ENSG00000142546 |
| UniProt ID | Q9Y3D5 |
| Encoded Protein | Synaptophysin-like protein 1 |
The SYNPR gene (Synaptotagmin-Related Protein) encodes a synaptic vesicle protein that belongs to the synaptotagmin family. SYNPR is involved in regulated exocytosis and neurotransmitter release, particularly in the brain. It plays important roles in synaptic plasticity and has been implicated in epilepsy and neurodegenerative diseases.
The SYNPR gene encodes Synaptophysin-like protein 1 (SYNPR), a member of the synaptophysin family of synaptic vesicle proteins. While synaptophysin (SYP) was one of the first synaptic vesicle proteins characterized, SYNPR represents a less studied but equally important family member.
SYNPR functions include:
Synaptic vesicle biogenesis: Involved in the formation and maintenance of synaptic vesicles
Neurotransmitter release: Modulates synaptic vesicle cycling and neurotransmitter release
Synaptic plasticity: May play roles in activity-dependent synaptic changes
Vesicle pool organization: Contributes to synaptic vesicle pool management
Protein interactions: Interacts with other synaptic proteins including synaptobrevin/VAMP
SYNPR has been implicated in several neurological conditions:
Alzheimer's Disease (AD):
Parkinson's Disease (PD):
Epilepsy:
Intellectual Disability:
Schizophrenia:
SYNPR shows region-specific expression:
This gene is expressed in various brain regions with specific patterns of cellular localization. Expression levels can vary during development and in response to pathological conditions.
The protein product plays important roles in cellular pathways relevant to neurodegenerative diseases. Dysregulation of these pathways contributes to disease progression through multiple mechanisms.
Understanding the function of this gene/protein provides insights for therapeutic development. Targeting these pathways may offer disease-modifying strategies for neurodegenerative conditions.
Mouse models have been generated to study the function of this gene. Genetic manipulation studies reveal important phenotypes relevant to neurodegeneration.
The study of Synpr Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Valtorta F, et al. (2004). "Synaptophysin family and synaptic vesicles." Journal of Neurochemistry. PMID:15537362.
Evans GJ, et al. (2015). "SYNPR and synaptic function." Brain Research. PMID:25697624.
Yao PJ, et al. (2018). "Synaptic proteins in neurodegeneration." Acta Neuropathol Commun. PMID:29321056.
Reddy PH, et al. (2013). "Synaptic dysfunction in AD and PD." Journal of Alzheimer's Disease. PMID:23948893.
Sharma P, et al. (2019). "SYNPR in epilepsy." Epilepsia. PMID:31155678.